Pfizer, Kintor in deal for ACVRL1 mab

Pfizer Inc. (NYSE:PFE) granted Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) exclusive, worldwide

Read the full 126 word article

User Sign In